Products from TargetMol
TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.
More information at: www.targetmol.com
Item number: TGM-T2269-100mg
| Keywords: | Wy-14643, NSC 310038 |
| Application: | PPARalpha activator |
| CAS | 50892-23-4 |
| MW: | 323.8 D |
Item number: TGM-T22692-100mg
| Application: | Low affinity, selective, non-competitive mGluR1b antagonist |
| CAS | 179067-99-3 |
| MW: | 247.25 D |
Item number: TGM-T2270-100mg
| Keywords: | Tranilast trans- |
| CAS | 70806-55-2 |
| MW: | 327.33 D |
Item number: TGM-T22713-10mg
| CAS | 3733-63-9 |
| MW: | 340.46 D |
Item number: TGM-T2272-100mg
| Keywords: | BPR1J097 |
| Application: | FLT3 inhibitor |
| CAS | 1327167-19-0 |
| MW: | 516.61 D |
Item number: TGM-T22729-1mL
| CAS | 123350-57-2 |
| MW: | 750.96 D |
Item number: TGM-T2273-100mg
| Application: | TGF-beta inhibitor, TGF-beta receptor type II degradation inducer |
| CAS | 1099644-42-4 |
| MW: | 415.52 D |
Item number: TGM-T22744-10mg
| Keywords: | PD 116948 |
| Application: | Adenosine A1 receptor antagonist |
| CAS | 102146-07-6 |
| MW: | 304.39 D |
Item number: TGM-T23184-1mL
| CAS | 75799-18-7 |
| MW: | 867.07 D |
Item number: TGM-T2320-1mL
| Application: | Targets adrenergic receptor beta-2 (ADRB2) |
| CAS | 312753-06-3 |
| MW: | 392.49 D |
Item number: TGM-T23210-1g
| Keywords: | Quinacrine (hydrochloride hydrate) (83-89-6 free base) |
| MW: | 472.9 D |
Item number: TGM-T2324-100mg
| Keywords: | TMC114 |
| Application: | Targets HIV protease [EC:3.4.23.16 3.4.23.47] (PR) |
| CAS | 206361-99-1 |
| MW: | 547.66 D |